Cargando…

Subtype Specific Elevated Expression of Hyaluronidase-1 (HYAL-1) in Epithelial Ovarian Cancer

BACKGROUND: Epithelial ovarian cancer (EOC) is morphologically heterogeneous being classified as serous, endometrioid, clear cell, or mucinous. Molecular genetic analysis has suggested a role for tumor suppressor genes located at chromosome 3p in serous EOC pathogenesis. Our objective was to evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoffou, Paule Héléna, Edjekouane, Lydia, Meunier, Liliane, Tremblay, André, Provencher, Diane Michèle, Mes-Masson, Anne-Marie, Carmona, Euridice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112150/ https://www.ncbi.nlm.nih.gov/pubmed/21695196 http://dx.doi.org/10.1371/journal.pone.0020705

Ejemplares similares

Proximal and distal regulation of the HYAL1 gene cluster by the estrogen receptor α in breast cancer cells
por: Edjekouane, Lydia, et al.
Publicado: (2016)

Expression of Hyaluronan Synthases (HAS1–3) and Hyaluronidases (HYAL1–2) in Serous Ovarian Carcinomas: Inverse Correlation between HYAL1 and Hyaluronan Content
por: Nykopp, Timo K, et al.
Publicado: (2009)

Cumulative defects in DNA repair pathways drive the PARP inhibitor response in high-grade serous epithelial ovarian cancer cell lines
por: Fleury, Hubert, et al.
Publicado: (2016)

Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer
por: Benhadjeba, Samira, et al.
Publicado: (2018)

Modeling the Diversity of Epithelial Ovarian Cancer through Ten Novel Well Characterized Cell Lines Covering Multiple Subtypes of the Disease
por: Sauriol, Alexandre, et al.
Publicado: (2020)

Autodisplay of Human Hyaluronidase Hyal-1 on Escherichia coli and Identification of Plant-Derived Enzyme Inhibitors
por: Orlando, Zoya, et al.
Publicado: (2015)

Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma
por: Nykopp, Timo K, et al.
Publicado: (2010)

Ran GTPase: A Key Player in Tumor Progression and Metastasis
por: Boudhraa, Zied, et al.
Publicado: (2020)

Ran promotes membrane targeting and stabilization of RhoA to orchestrate ovarian cancer cell invasion
por: Zaoui, Kossay, et al.
Publicado: (2019)

HYAL1 and HYAL2 Inhibit Tumour Growth In Vivo but Not In Vitro
por: Wang, Fuli, et al.
Publicado: (2008)

Monocytes/Macrophages Upregulate the Hyaluronidase HYAL1 and Adapt Its Subcellular Trafficking to Promote Extracellular Residency upon Differentiation into Osteoclasts
por: Puissant, Emeline, et al.
Publicado: (2016)

Transforming growth factor-β1 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts
por: Chang, Nan-Shan
Publicado: (2002)

NR1D1 regulation by Ran GTPase via miR4472 identifies an essential vulnerability linked to aneuploidy in ovarian cancer
por: Boudhraa, Zied, et al.
Publicado: (2021)

Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer
por: Asare-Werehene, Meshach, et al.
Publicado: (2019)

A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma
por: Le Page, Cécile, et al.
Publicado: (2019)

Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo models
por: Brodeur, Melica Nourmoussavi, et al.
Publicado: (2021)

A nonsynonymous polymorphism (rs117179004, T392M) of hyaluronidase 1 (HYAL1) is associated with increased risk of idiopathic pulmonary fibrosis in Southern Han Chinese
por: Liu, Juan, et al.
Publicado: (2021)

Mutations in HYAL2, Encoding Hyaluronidase 2, Cause a Syndrome of Orofacial Clefting and Cor Triatriatum Sinister in Humans and Mice
por: Muggenthaler, Martina M. A., et al.
Publicado: (2017)

Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis
por: Tsofack, Serges P, et al.
Publicado: (2013)

Carboplatin sensitivity in epithelial ovarian cancer cell lines: The impact of model systems
por: Patra, Bishnubrata, et al.
Publicado: (2020)

PRP4K is a HER2-regulated modifier of taxane sensitivity
por: Corkery, Dale P, et al.
Publicado: (2015)

Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease
por: Fleury, Hubert, et al.
Publicado: (2015)

RAN Nucleo-Cytoplasmic Transport and Mitotic Spindle Assembly Partners XPO7 and TPX2 Are New Prognostic Biomarkers in Serous Epithelial Ovarian Cancer
por: Cáceres-Gorriti, Katia Y., et al.
Publicado: (2014)

BMP-2 signaling in ovarian cancer and its association with poor prognosis
por: Le Page, Cécile, et al.
Publicado: (2009)

The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicin
por: Andreev, Emil, et al.
Publicado: (2016)

Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly(ADP-ribose) polymerase inhibitor resistance in high-grade serous ovarian cancer
por: Sauriol, Alexandre, et al.
Publicado: (2023)

Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases
por: Tabariès, Sébastien, et al.
Publicado: (2015)

Hyal1 Expression in Colorectal Carcinoma Cell Migration and Invasiveness: Significance and Mechanism
por: Zhao, Shuangshuang, et al.
Publicado: (2022)

Influence of Association on Binding of Disaccharides to YKL-39 and hHyal-1 Enzymes
por: Krzemińska, Agnieszka, et al.
Publicado: (2022)

Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes
por: Asare-Werehene, Meshach, et al.
Publicado: (2022)

Retracted: Hyal1 Expression in Colorectal Carcinoma Cell Migration and Invasiveness: Significance and Mechanism
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

HYAL1 Is Downregulated in Idiopathic Pulmonary Fibrosis and Inhibits HFL-1 Fibroblast Proliferation When Upregulated
por: Leng, Dong, et al.
Publicado: (2020)

Elucidating the clinical spectrum and molecular basis of HYAL2 deficiency
por: Fasham, James, et al.
Publicado: (2022)

Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence
por: Fleury, Hubert, et al.
Publicado: (2019)

Predictive and Prognostic Protein Biomarkers in Epithelial Ovarian Cancer: Recommendation for Future Studies
por: Le Page, Cécile, et al.
Publicado: (2010)

HYAL3 as a potential novel marker of BLCA patient prognosis
por: Liu, Jun-peng, et al.
Publicado: (2022)

Upregulation of HYAL1 Expression in Breast Cancer Promoted Tumor Cell Proliferation, Migration, Invasion and Angiogenesis
por: Tan, Jin-Xiang, et al.
Publicado: (2011)

Improved Surface Display of Human Hyal1 and Identification of Testosterone Propionate and Chicoric Acid as New Inhibitors
por: Lengers, Isabelle, et al.
Publicado: (2020)

Expression of Stem Cell Markers in Preinvasive Tubal Lesions of Ovarian Carcinoma
por: Chene, G., et al.
Publicado: (2015)

Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin
por: Gerber, Emma, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a01l3cr5rmtpthmv0vt2pv1uut